Zhiping Wang

7.9k total citations
332 papers, 5.2k citations indexed

About

Zhiping Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zhiping Wang has authored 332 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 92 papers in Pulmonary and Respiratory Medicine and 89 papers in Surgery. Recurrent topics in Zhiping Wang's work include Bladder and Urothelial Cancer Treatments (38 papers), Urinary Bladder and Prostate Research (30 papers) and Epigenetics and DNA Methylation (19 papers). Zhiping Wang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (38 papers), Urinary Bladder and Prostate Research (30 papers) and Epigenetics and DNA Methylation (19 papers). Zhiping Wang collaborates with scholars based in China, United States and South Korea. Zhiping Wang's co-authors include Shicui Zhang, Hanzhang Wang, Guangfeng Wang, Jing‐Song Ou, Junqiang Tian, Yuejun Tian, Ronald Rodríguez, Wan Du, Rui Xu and Zhilong Dong and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Zhiping Wang

313 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiping Wang China 39 1.7k 839 778 642 633 332 5.2k
Takashi Deguchi Japan 46 2.2k 1.3× 1.1k 1.3× 1.3k 1.7× 299 0.5× 585 0.9× 388 7.9k
Yasuhiro Hashimoto Japan 41 3.4k 2.0× 1.0k 1.2× 1.2k 1.6× 1.2k 1.9× 712 1.1× 358 7.9k
Annalisa Santucci Italy 49 3.3k 1.9× 1.0k 1.2× 1.2k 1.5× 891 1.4× 920 1.5× 303 10.4k
Shaogang Wang China 34 1.3k 0.7× 1.7k 2.1× 758 1.0× 292 0.5× 378 0.6× 361 5.0k
Hiroyuki Nishiyama Japan 38 2.3k 1.3× 1.1k 1.3× 2.6k 3.3× 557 0.9× 1.2k 2.0× 420 6.2k
Fumio Nomura Japan 53 3.3k 1.9× 991 1.2× 1.4k 1.8× 700 1.1× 1.3k 2.0× 396 9.1k
David Murray United States 48 4.0k 2.3× 834 1.0× 543 0.7× 612 1.0× 1.5k 2.4× 286 9.7k
Yoshitaka Isaka Japan 53 4.1k 2.4× 1.2k 1.5× 1.3k 1.7× 1.2k 1.9× 759 1.2× 395 12.2k
Susan J. Keam New Zealand 49 1.9k 1.1× 877 1.0× 749 1.0× 621 1.0× 1.6k 2.6× 211 7.3k
Makiko Fujii Japan 40 3.4k 2.0× 839 1.0× 359 0.5× 252 0.4× 942 1.5× 188 6.2k

Countries citing papers authored by Zhiping Wang

Since Specialization
Citations

This map shows the geographic impact of Zhiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiping Wang more than expected).

Fields of papers citing papers by Zhiping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiping Wang. The network helps show where Zhiping Wang may publish in the future.

Co-authorship network of co-authors of Zhiping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiping Wang. A scholar is included among the top collaborators of Zhiping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiping Wang. Zhiping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Yuwen, Hui Cheng, Junqiang Tian, et al.. (2025). SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway. Communications Biology. 8(1). 36–36. 4 indexed citations
2.
He, Wei, Li Lu, Dongmin Wang, et al.. (2024). Efficacy and safety of preventing catheter-associated urinary tract infection by inhibiting catheter bacterial biofilm formation: a multicenter randomized controlled trial. Antimicrobial Resistance and Infection Control. 13(1). 96–96. 4 indexed citations
3.
Zhang, Jinyu, et al.. (2024). Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin. Scientific Reports. 14(1). 28103–28103. 1 indexed citations
4.
Wang, Yuhan, Hanzhang Wang, Hui Ding, et al.. (2024). Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis. Future Oncology. 22(5). 567–582. 1 indexed citations
5.
Zhang, Luyang, Hui Ding, Junqiang Tian, et al.. (2024). Risk factors of high fluid absorption in patients treated with mini-PCNL: a single-center prospective study. World Journal of Urology. 42(1). 114–114. 1 indexed citations
7.
Zhang, Mi, Cheng‐Jie Yang, Jia‐Xuan Yan, et al.. (2023). Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I. Bioorganic Chemistry. 139. 106652–106652. 11 indexed citations
8.
Yu, Yilin, Hui Li, Hongying Zheng, et al.. (2023). Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma. Frontiers in Immunology. 14. 1066255–1066255. 5 indexed citations
9.
Yang, H. J., Lingyun Liu, Zhiping Wang, et al.. (2023). Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy. Journal of Immunology Research. 2023. 1–12. 8 indexed citations
10.
Zhang, Yuanfeng, et al.. (2023). Association of dietary carotenoid intake with the prevalence kidney stones among the general adult population. International Urology and Nephrology. 56(2). 423–431. 3 indexed citations
11.
Wang, Zhiping, et al.. (2023). The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies. Stem Cells International. 2023. 1–15. 7 indexed citations
12.
Wang, Zhiping, et al.. (2022). CT location distribution of subarachnoid hemorrhage and its value in intracranial aneurysm detection. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Hu, Weiwei, Zhilong Dong, Junqiang Tian, et al.. (2022). The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 26(3). 483–494. 9 indexed citations
14.
Cheng, Hui, et al.. (2022). ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer. Clinical & Translational Oncology. 25(5). 1425–1435. 8 indexed citations
15.
Zhang, Meng, Chen Jin, Jialin Meng, et al.. (2022). Identification of novel susceptibility factors related to CP/CPPS‐like symptoms: Evidence from a multicenter case‐control study. The Prostate. 82(7). 772–782. 5 indexed citations
16.
Dong, Zhilong, Yiran Wang, Hui Cheng, et al.. (2021). Li‐ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models. Andrology. 9(5). 1593–1602. 33 indexed citations
17.
Wang, Zhiping, et al.. (2019). Progress in the treatment of Bladder Urothelial Carcinoma with PD-1 / PD-L inhibitor. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Wang, Yifei, et al.. (2015). Anti-hepatocarcinoma Effects of a Food Additive Resveratrol Nanosuspension Against Human HepG2 Cells. Advance Journal of Food Science and Technology. 8(3). 210–213. 3 indexed citations
19.
Meng, Xiangping, et al.. (2015). RP-HPLC-UV Method for Simultaneous Determination of Nine Isoflavonoids in Huangqi-Gegen Herbal Pair. Advance Journal of Food Science and Technology. 7(3). 173–176. 1 indexed citations
20.
Xu, Bo, Li Zhou, Feng-Jun Chang, et al.. (2012). Simvastatin Reduces Myocardial Injury Undergoing Noncoronary Artery Cardiac Surgery. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2304–2313. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026